USPTO serial 79185467
K
Reviewed by CopyMark Law Group
Reg. 5202159Status 404
- Filing date
- Status date
- Registration date
- May 16, 2017
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with K?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; chemicals for use in the manufacture of dietary supplements and foods; chemical additives for use in the manufacture of dietary supplements and foods; amino acids for use in the manufacture of dietary supplements and foods; bacteriological culture mediums other than for medical or veterinary purposes; cell culture mediums other than for medical or veterinary purposes; cell culture mediums for research and for scientific purposes, other than for medical or veterinary purposes; plant growth regulating preparations; artificial sweeteners | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceuticals for the treatment of cancer and malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; pharmaceutical preparations, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceutical preparations for the treatment of cancer and malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes for use in augmentation, differentiation and cultivation of bone, tissue and cells; cell culture mediums for medical and veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells; cell culture mediums for research and for scientific purposes and for medical or veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages, namely, juice drinks, jelly drinks and milk adapted for medical purposes; dietetic foods, namely, crackers, candy, jelly adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animals | SECTION 71 - CANCELLED | — |
| 010 | Apparatus for use in medical analysis, namely, apparatus for analysis of biological materials for medical purposes, apparatus for analysis of chemicals for medical purposes, apparatus for analysis of drugs, apparatus for analysis of drug metabolites, medical diagnostic instruments for the analysis of body fluids; medical apparatus, namely, injection device for pharmaceuticals, injection needles for medical purposes, inhalation device for pharmaceuticals, defibrillators, medical apparatus for treating respiratory conditions, infusion devise for administering drugs, infusion pumps for delivering measured amounts of solutions into the bloodstream over time, blood transfusion apparatus, blood component separation apparatus for medical purposes, diagnostic apparatus for detecting cancer, diagnostic apparatus for detecting infection, diagnostic apparatus for detecting the disease state of human illnesses, containers and trays specially designed for transporting and holding pharmaceuticals, high frequency electromagnetic therapy apparatus, low frequency electric therapy apparatus, short wave therapy machines and apparatus, static electric therapy apparatus, ultraviolet radiator units for therapeutic purposes, infrared radiator units for therapeutic purposes, mercury arc lamp units for therapeutic purposes, carbon arc lamp units for therapeutic purposes, massage apparatus for medical purposes; medical instruments, namely, for use in injection for administering drugs, infusion for administering drugs, inhalation for administering drugs, transfusion, separation of blood component for medical purposes, diagnosis for detecting cancer, diagnosis for detecting infection, diagnosis for detecting the disease state of human illnesses, transporting and holding pharmaceuticals, analysis of biological materials for medical purposes, analysis of chemicals for medical purposes, analysis of drugs, analysis of drug metabolites, analysis of body fluids; surgical apparatus, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; surgical instruments, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; gloves for medical purposes | SECTION 71 - CANCELLED | — |
| 040 | Custom manufacture of pharmaceuticals; extraction, production and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for others | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research; research of chemicals; analysis of chemicals; testing, inspection or research of pharmaceuticals; testing, inspection or research of chemicals; testing, inspection or research of cosmetics; testing, inspection or research of foodstuff; providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development; rental of laboratory apparatus; rental of laboratory instruments | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kyowa Hakko Kirin Co., Ltd.
- Other trademarks owned by Kyowa Hakko Kirin Co., Ltd.
- Other trademarks owned by Kyowa Hakko Kirin Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named K
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jul 2, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 24, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 8, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 8, 2024 | INPC | INVALIDATION PROCESSED | — |
| Aug 2, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 1, 2023 | C71T | CANCELLED SECTION 71 | — |
| May 16, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 20, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 22, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 22, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 16, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 16, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 24, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 26, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 7, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 18, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 18, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 27, 2016 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Oct 27, 2016 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Oct 27, 2016 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Oct 5, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 3, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 3, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 3, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 12, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 12, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2016 | ALIE | ASSIGNED TO LIE | — |
| Aug 3, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 14, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 11, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 11, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 1, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 31, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |